Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

MCHPP vs NOVTU: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MCHPP Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 6–0 Matrix Metrics)

MCHPP Overall Winner 6-Pillar Tally: MCHPP 4 – 0 NOVTU (2 Tie) Matrix Metrics: MCHPP 6 – 0 NOVTU

As of Nov 16, 2026, Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) is the stronger overall head-to-head candidate over NOVTU (NOVTU) in the Tradestie Institutional Equity Comparison Engine, winning 6–0 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MCHPP carries a Unified Composite Score of 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin), whereas NOVTU carries 42.5/100 (HOLD) at $50.76 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: MCHPP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3); meanwhile NOVTU is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MCHPP vs NOVTU
MCHPP NASDAQ Head-to-Head Winner
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Semiconductors & Related Devices
$52.64
-3.18% 1D
Market Cap N/A
TTM Revenue $5.60B
Forward P/E N/M
Beta / 30D Vol 2.16β · 65% Vol
Unified Composite Score
57.1 / 100 HOLD
Tech 74.0 Fund 61.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 32
RSI-14: 32.3 · SMA20: $61.25 · SMA50: $63.22
NOVTU US Equity
NOVTU
Institutional Equity
$50.76
-1.05% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.70β · 65% Vol
Unified Composite Score
42.5 / 100 HOLD
Tech 30.0 Fund 45.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.0%), weak momentum, RSI 33
RSI-14: 33.1 · SMA20: $58.29 · SMA50: $59.48

6-Pillar Scorecard Institutional Category Breakdown (MCHPP 4 – 0 NOVTU)

Columns: Metric · MCHPP · NOVTU
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale MCHPP
Revenue Growth (YoY) +42.2% N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) $5.60B N/A
Market Cap N/A N/A
3. Profitability & Quality MCHPP
Gross Margin 62.7% N/A
Operating Margin 21.6% N/A
Net Profit Margin 15.0% N/A
Return on Equity (ROE) 12.6% N/A
4. Balance Sheet & Cash Flow MCHPP
Cash Generation (TTM) $1.87B EBITDA N/A
Cash Flow Margin 33.3% EBITDA Mgn N/A
Net Cash / Leverage $12.20 Book/Sh · 12.6% ROE N/A ROE
Dividend Yield 6.84% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat MCHPP
OpEx & R&D Intensity 41.1% of Rev ($2.30B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Semiconductors Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MCHPP (6) vs NOVTU (0)
Institutional Metric MCHPP NOVTU Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+42.2% N/A Higher Growth MCHPP
Operating Margin (TTM)
Profitability
21.6% N/A Higher Margin MCHPP
Net Profit Margin
Profitability
15.0% N/A Higher Margin MCHPP
Return on Equity (ROE)
Capital Efficiency
12.6% N/A Higher ROE MCHPP
52-Week Range Position
Momentum
14% ($47–$88) 11% ($48–$77) Stronger Trend MCHPP
Beta / 30D Volatility
Risk Regime
2.16β · 65% Vol 1.70β · 65% Vol Lower Realized Risk Tie
Unified Institutional Score
Composite Signal
57.1 / 100 (HOLD) 42.5 / 100 (HOLD) Higher Composite MCHPP
Trailing 12M Revenue (USD)
Operating Scale
$5.60B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
62.7% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.87B EBITDA ($12.20 Book/Sh · 12.6% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NOVTU +8.2 pp
MCHPP: -17.41% · NOVTU: -9.21%
3M Horizon MCHPP +3.36 pp
MCHPP: -23.67% · NOVTU: -27.03%
6M Horizon NOVTU +12.47 pp
MCHPP: -36.06% · NOVTU: -23.59%
1Y Horizon MCHPP +1.29 pp
MCHPP: +0.8% · NOVTU: -0.49%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MCHPP vs NOVTU. Trailing 12-month operating profitability (MCHPP 21.6% vs NOVTU N/A) and valuation multiples (MCHPP N/M vs NOVTU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

MCHPP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.60B
Gross Margin62.7%
Op. Margin21.6%
ROE / Fwd P/E12.6% · N/M
NOVTU ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MCHPP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MCHPP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NOVTU UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NOVTU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MCHPP Moat Profile Scale & Operating Efficiency Moat
Semiconductors Operator
Competes within the Semiconductors value chain with N/A market capitalization and 21.6% operating margin.
OpEx & R&D Reinvestment 41.1% of Rev ($2.30B)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (19 partners):
Taiwan Semiconductor Manufacturing Company United Microelectronics Corporation Amkor Technology ASE Technology Holding
NOVTU Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ MCHPP vs NOVTU Key Questions & Quantitative Answers

As of Nov 16, 2026, Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) is the stronger overall head-to-head candidate over NOVTU (NOVTU) in the Tradestie Institutional Equity Comparison Engine, winning 6–0 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MCHPP carries a Unified Composite Score of 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin), whereas NOVTU carries 42.5/100 (HOLD) at $50.76 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: MCHPP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3); meanwhile NOVTU is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MCHPP leads the Growth & Scale pillar: MCHPP posts +42.2% YoY revenue growth and N/A YoY earnings growth on $5.60B TTM revenue (62.7% gross margin, 21.6% operating margin), compared with NOVTU at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, MCHPP generates $5.60B in USD-normalized revenue versus N/A for NOVTU. In operating R&D and SG&A reinvestment, MCHPP deploys 41.1% of Rev ($2.30B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NOVTU.

MCHPP and NOVTU trade at balanced relative valuation multiples. MCHPP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (33.3% EBITDA margin), whereas NOVTU trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MCHPP (12.6% ROE) versus NOVTU (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, MCHPP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.16β · 65% Vol realized risk). By comparison, NOVTU carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.70β · 65% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.